Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medulloblastomas.

L N Sutton1, R J Packer, L Schut

  • 1University of Pennsylvania School of Medicine, Philadelphia.

Neurosurgery Clinics of North America
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Significant advancements in pediatric medulloblastoma management include improved surgical techniques and adjuvant chemotherapy, leading to delayed recurrence. However, achieving a cure remains uncertain, necessitating further research into tumor biology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MRI Features of Histologically Diagnosed Supratentorial Primitive Neuroectodermal Tumors and Pineoblastomas in Correlation with Molecular Diagnoses and Outcomes: A Report from the Children's Oncology Group ACNS0332 Trial.

AJNR. American journal of neuroradiology·2019
Same author

Treatment of pediatric cerebral radiation necrosis: a systematic review.

Journal of neuro-oncology·2016
Same author

Remarkable oxide ion conductivity observed at low temperatures in a complex superstructured oxide.

Advanced materials (Deerfield Beach, Fla.)·2010
Same author

CNS germ cell tumor (CNSGCT) of childhood: presentation and delayed diagnosis.

Neurology·2007
Same author

NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight.

Neurology·2007
Same author

Treatment strategies for medulloblastoma and primitive neuroectodermal tumors.

Neurosurgical focus·2006
Same journal

Intramedullary Spinal Cord Tumors.

Neurosurgery clinics of North America·2026
Same journal

Spinal Cord Deformities Associated with Intramedullary Spinal Cord Tumors.

Neurosurgery clinics of North America·2026
Same journal

Radiation Therapy for Spinal Cord Tumors.

Neurosurgery clinics of North America·2026
Same journal

Treatment Strategies of Intramedullary Spinal Cord Tumors.

Neurosurgery clinics of North America·2026
Same journal

Vascular Lesions of the Spinal Cord: Arteriovenous and Cavernous Malformations.

Neurosurgery clinics of North America·2026
Same journal

Hemangioblastomas of the Spinal Cord.

Neurosurgery clinics of North America·2026
See all related articles

Area of Science:

  • Pediatric Oncology
  • Neuro-oncology
  • Cancer Therapeutics

Background:

  • Medulloblastoma management has seen considerable progress over the past decade.
  • Improvements in surgical techniques have enabled more aggressive resection with reduced patient morbidity.
  • Staging advancements allow for reduced radiation therapy doses, potentially improving neuropsychological outcomes.

Purpose of the Study:

  • To review recent advancements in the management of pediatric medulloblastoma.
  • To highlight the impact of improved surgical techniques, staging, and adjuvant chemotherapy.
  • To identify future research directions for achieving a cure.

Main Methods:

  • Review of recent clinical advancements in medulloblastoma treatment.
  • Analysis of the impact of surgical, radiotherapeutic, and chemotherapeutic strategies.

Related Experiment Videos

  • Discussion of current limitations and future research needs.

    • Main Results:

    • Improved surgical techniques have decreased morbidity.
    • Staging has enabled radiation dose reduction in select patients.
    • Adjuvant chemotherapy is effective in delaying recurrence for high-risk medulloblastoma patients.

    Conclusions:

    • While progress has been made, a definitive cure for medulloblastoma is not yet established.
    • Future therapeutic breakthroughs depend on a deeper understanding of medulloblastoma biology, including immunology, cytogenetics, and biochemistry.
    • Continued research is crucial for developing novel treatment modalities.